Cargando…
Ocrelizumab-induced alopecia areata—A series of five patients from Ontario, Canada: A case report
BACKGROUND: Ocrelizumab is a humanized monoclonal antibody that targets the CD20 antigen found on B-cells. It is indicated in the treatment of both relapsing–remitting multiple sclerosis and primary progressive multiple sclerosis. OBJECTIVE: The aim of this study is to report and describe the charac...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233903/ https://www.ncbi.nlm.nih.gov/pubmed/32477559 http://dx.doi.org/10.1177/2050313X20919614 |